CYAD-02

Overview

CYAD-02 is a Chimeric Antigen Receptor-T (CAR-T) cell therapy that targets cancer cells that express NKG2D. 

SparkCures ID 607
Generic Name CYAD-02
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.